Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C6H5O7.2Ca.Fe |
| Molecular Weight | 514.2 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Ca++].[Ca++].[Fe++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
InChI
InChIKey=HSBFYEQJGSVAJW-UHFFFAOYSA-H
InChI=1S/2C6H8O7.2Ca.Fe/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;;3*+2/p-6
| Molecular Formula | Fe |
| Molecular Weight | 55.845 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C6H5O7 |
| Molecular Weight | 189.0997 |
| Charge | -3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Ca |
| Molecular Weight | 40.078 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/14116934http://www.foodchemadditives.com/products/Ferrous-Lactatehttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfDOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016https://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttp://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502Curator's Comment: description was created based on several sources, including
http://www.minapharm.com/Public/ProductDetails.aspx?ProductCode=FERRO_SANO&langParam=en
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14116934http://www.foodchemadditives.com/products/Ferrous-Lactatehttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfDOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016https://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttp://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502
Curator's Comment: description was created based on several sources, including
http://www.minapharm.com/Public/ProductDetails.aspx?ProductCode=FERRO_SANO&langParam=en
Iron(II) gluconate (also known as a ferrous gluconate) is used in the treatment of hypochromic anemia. The real problem of iron therapy is not the theoretical utilization of iron, or the reticulocyte response, or even the daily increase of hemoglobin. These are important only as they indicate the return of the patients' blood to normal in a reasonably short time without undue inconvenience. Most patients suffering from hypochromic anemia respond well to most forms of iron when administered in adequate dosage. For the patients who cannot tolerate the usual iron compounds, it is important to have a medication which is effective and which causes minimum disturbance. Ferrous gluconate is such a medicament.
Originator
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Palliative | Unknown Approved UseUnknown |
|||
| Palliative | Unknown Approved UseUnknown |
|||
| Primary | Ferro Sanol Duodenal Approved UseFerro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia. |
|||
PubMed
| Title | Date | PubMed |
|---|---|---|
| FERROUS IODIDE AS A SUBSTITUTE FOR VITAMIN A IN RATS. | 1932 Jul 1 |
|
| [FERROUS ASPARTATE IN THERAPY]. | 1964 Jan 1 |
|
| Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis. | 2007 |
|
| The effect of iron treatment on adhesion molecules in patients with iron deficiency anemia. | 2010 Dec |
|
| Tolerability of different oral iron supplements: a systematic review. | 2013 Apr |
|
| A practical and successful desensitization protocol for immediate hypersensitivity reactions to iron salts. | 2014 |
|
| Synthesis of phosphabenzenes by an iron-catalyzed [2+2+2] cycloaddition reaction of diynes with phosphaalkynes. | 2015 Jun 22 |
|
| Reactivity enhancement of iron sulfide nanoparticles stabilized by sodium alginate: Taking Cr (VI) removal as an example. | 2017 Jul 5 |
|
| Continuous sulfidogenic wastewater treatment with iron sulfide sludge oxidation and recycle. | 2017 May 1 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:31:52 GMT 2023
by
admin
on
Fri Dec 15 15:31:52 GMT 2023
|
| Record UNII |
4P1IZU59M5
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB130515
Created by
admin on Fri Dec 15 15:31:52 GMT 2023 , Edited by admin on Fri Dec 15 15:31:52 GMT 2023
|
PRIMARY | |||
|
SUB13173MIG
Created by
admin on Fri Dec 15 15:31:52 GMT 2023 , Edited by admin on Fri Dec 15 15:31:52 GMT 2023
|
PRIMARY | |||
|
7600-56-8
Created by
admin on Fri Dec 15 15:31:52 GMT 2023 , Edited by admin on Fri Dec 15 15:31:52 GMT 2023
|
NON-SPECIFIC STOICHIOMETRY | |||
|
4P1IZU59M5
Created by
admin on Fri Dec 15 15:31:52 GMT 2023 , Edited by admin on Fri Dec 15 15:31:52 GMT 2023
|
PRIMARY | |||
|
DTXSID60226906
Created by
admin on Fri Dec 15 15:31:52 GMT 2023 , Edited by admin on Fri Dec 15 15:31:52 GMT 2023
|
PRIMARY | |||
|
m611
Created by
admin on Fri Dec 15 15:31:52 GMT 2023 , Edited by admin on Fri Dec 15 15:31:52 GMT 2023
|
PRIMARY | |||
|
10097975
Created by
admin on Fri Dec 15 15:31:52 GMT 2023 , Edited by admin on Fri Dec 15 15:31:52 GMT 2023
|
PRIMARY | |||
|
258-703-5
Created by
admin on Fri Dec 15 15:31:52 GMT 2023 , Edited by admin on Fri Dec 15 15:31:52 GMT 2023
|
PRIMARY | |||
|
53684-61-0
Created by
admin on Fri Dec 15 15:31:52 GMT 2023 , Edited by admin on Fri Dec 15 15:31:52 GMT 2023
|
PRIMARY | |||
|
100000076565
Created by
admin on Fri Dec 15 15:31:52 GMT 2023 , Edited by admin on Fri Dec 15 15:31:52 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |